Course Description

The implementation of Directive 2001/20/EC has brought profound changes to the way clinical trials are conducted in the EU and equally important changes to the way IMPs are manufactured and controlled. Few people within the pharmaceutical and healthcare sectors would question the wisdom of greater uniformity of approach to the conduct of clinical trials in Europe, but the application of the Directive is proving to be a significant challenge to manufacturers of clinical supplies…

Learn More